Last reviewed · How we verify
NCT07141537: CaBooM
Caloric Balance Markers Study
trial in Metabolism in 400 participants. Currently enrolling.
31 August 2033
Quick facts
| Lead sponsor | Institute for Systems Biology |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 27 August 2025 |
| Primary completion | 31 August 2033 |
| Estimated completion | 31 August 2033 |
| Sites | 1 location across United States |
Conditions studied
- Metabolism — all drugs for Metabolism →
Sponsor
Institute for Systems Biology
Who can join
18 and older, any sex, with Metabolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07141537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolism
Currently open trials in the same condition.
- NCT06930976 — Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells · NA · recruiting
- NCT06907329 — The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and · NA · recruiting
- NCT06813261 — GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women · NA · recruiting
- NCT06754709 — Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children · recruiting
- NCT06846840 — Ketone Esters and Metabolism During Recovery from Endurance Exercise · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07141537 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute for Systems Biology
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07141537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing